½ÃÀ庸°í¼­
»óǰÄÚµå
1308012

¼¼°èÀÇ ¼ö¸é¹«È£Èí¿ë ÀÇ·á±â±â ½ÃÀå ±Ô¸ð, Á¡À¯À² ¹× ¼ºÀå ºÐ¼® : ÀÇ·á±â±â À¯Çüº°, ÃÖÁ¾»ç¿ëÀÚº° - »ê¾÷ ¿¹Ãø(2023-2030³â)

Global Sleep Apnea Devices Market Size, Share, Growth Analysis, By Device Type(Therapeutic Devices, Diagnostic Devices), By End-User(Sleep Laboratories & Clinics, Homecare & Other Settings) - Industry Forecast 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: SkyQuest | ÆäÀÌÁö Á¤º¸: ¿µ¹® 157 Pages | ¹è¼Û¾È³» : 3-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ¼ö¸é¹«È£Èí¿ë ÀÇ·á±â±â ½ÃÀå ±Ô¸ð´Â 2022³â 75¾ï 9,000¸¸ ´Þ·¯¿¡¼­ 2030³â±îÁö 138¾ï 4,000¸¸ ´Þ·¯¿¡ À̸£°í, ¿¹Ãø ±â°£(2023-2030³â) µ¿¾È 6.9%ÀÇ CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ºñ¸¸ ¹× ±âŸ »ýȰ½À°ü ¹®Á¦ Áõ°¡, ¼±Áø±¹°ú °³¹ßµµ»ó±¹ ¸ðµÎ¿¡¼­ ¼ö¸é¹«È£ÈíÁõ Áø´ÜÀ² Áõ°¡´Â ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÏ´Â ¿äÀÎÀÔ´Ï´Ù.

ÀÌ º¸°í¼­´Â ¼¼°èÀÇ ¼ö¸é¹«È£Èí¿ë ÀÇ·á±â±â(Sleep Apnea Devices) ½ÃÀåÀ» Á¶»ç ºÐ¼®ÇÏ¿© ½ÃÀå ¿ªÇÐ ¹× Àü¸Á, ºÎ¹® ºÐ¼®, ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀÇ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

ÁÖ¿ä ¿ä¾à

Á¶»ç ¹æ¹ý

»óÀ§ ½ÃÀå ºÐ¼®

ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ®

  • ±â¼ú ºÐ¼®
  • °¡°Ý ºÐ¼®
  • °ø±Þ¸Á ºÐ¼®
  • ¹ë·ùüÀÎ ºÐ¼®
  • ½ÃÀå »ýŰè
  • IP ºÐ¼®
  • ¹«¿ª ºÐ¼®
  • ½ºÅ¸Æ®¾÷ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
  • Çõ½Å ¸ÅÆ®¸¯½º
  • ÆÄÀÌÇÁ¶óÀÎ Á¦Ç° ºÐ¼®
  • °Å½Ã°æÁ¦ ÁöÇ¥
  • ÁÖ¿ä ÅõÀÚ ºÐ¼®
  • ÁÖ¿ä ¼º°ø ¿äÀÎ
  • °æÀï Á¤µµ

½ÃÀå ¿ªÇаú Àü¸Á

  • ½ÃÀå ¿ªÇÐ
  • ¼ºÀå ÃËÁø¿äÀÎ
  • ±âȸ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • °úÁ¦
  • ±ÔÁ¦ »óȲ
  • PorterÀÇ Five Forces ºÐ¼®
  • ÇâÈÄ È¥¶õ¿¡ °üÇÑ Æ¯º°ÇÑ ÀλçÀÌÆ®

¼¼°èÀÇ ¼ö¸é¹«È£Èí¿ë ÀÇ·á±â±â ½ÃÀå : ±â±â À¯Çüº°

  • ½ÃÀå °³¿ä
  • Ä¡·á ±â±â
  • Áø´Ü ±â±â

¼¼°èÀÇ ¼ö¸é¹«È£Èí¿ë ÀÇ·á±â±â ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • ½ÃÀå °³¿ä
  • ¼ö¸é ¿¬±¸¼Ò ¹× Ŭ¸®´Ð
  • ȨÄÉ¾î ¹× ±âŸ ȯ°æ

¼¼°èÀÇ ¼ö¸é¹«È£Èí¿ë ÀÇ·á±â±â ½ÃÀå ±Ô¸ð : Áö¿ªº°

  • ½ÃÀå °³¿ä
  • ºÏ¹Ì
  • ¹Ì±¹
  • ij³ª´Ù
  • À¯·´
  • µ¶ÀÏ
  • ½ºÆäÀÎ
  • ÇÁ¶û½º
  • ¿µ±¹
  • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áß±¹
  • Àεµ
  • ÀϺ»
  • Çѱ¹
  • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • ºê¶óÁú
  • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
  • GCC ±¹°¡
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

°æÀï ±¸µµ

  • ÁÖ¿ä 5°³»ç ºñ±³
  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×(2021³â)
  • ÁÖ¿ä ½ÃÀå ±â¾÷ÀÌ Ã¤ÅÃÇÑ Àü·«
  • ÁÖ¿ä ¼º°ø Àü·«
  • ½ÃÀå¿¡¼­ÀÇ Ãֱ٠Ȱµ¿
  • ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À²(2021³â)

ÁÖ¿ä ±â¾÷ °³¿ä

  • Koninklijke Philips N.V.
  • ResMed
  • Fisher & Paykel Healthcare Limited
  • Invacare Corporation
  • DeVilbiss Healthcare LLC(a subsidiary of Drive DeVilbiss Healthcare)
  • BMC Medical Co., Ltd.
  • Natus Medical Incorporated
  • Weinmann Emergency Medical Technology GmbH + Co. KG
  • SOMNOmedics GmbH
  • Compumedics Limited
  • Braebon Medical Corporation
  • APEX Medical Corporation
  • Lowenstein Medical GmbH & Co. KG
  • Circadiance LLC
  • Curative Medical Inc.
  • Panthera Dental Inc.
  • NovaSom Inc.
  • Inspire Medical Systems, Inc.
  • Advanced Brain Monitoring, Inc.
  • Itamar Medical Ltd.
LSH 23.07.20

Sleep Apnea Devices Market size was valued at USD 7.1 billion in 2021 and is poised to grow from USD 7.59 billion in 2022 to USD 13.84 billion by 2030, growing at a CAGR of 6.9% in the forecast period (2023-2030).

An individual's uneven breathing pattern while they are asleep is a sign of the sleeping disorder sleep apnea. People with untreated sleep apnea experience erratic breathing while they sleep as a result of the brain and the rest of the body receiving insufficient oxygen. The likelihood of having this condition increases with age and the presence of conditions including diabetes, hypertension, cardiovascular disease, and others. The most prevalent type of sleep apnea in the world is obstructive sleep apnea (OSA), and its prevention necessitates early diagnosis and the use of treatment tools.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Sleep Apnea Devices Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report:

The Global Sleep Apnea Devices Market is segmented based on the Device type, End-User, and Region. Based on the Device Type, the Market is segmented into Therapeutic Devices and Diagnostic Devices. Based on the End-User, the Market is segmented as Sleep Laboratories & Clinics and Homecare & Other Settings. Based on Region it is categorized into North America, Europe, Asia-Pacific, Latin America, and MEA.

Driver

Increase in the Rate of Obstructive Sleep Apnea

People's sedentary lives are contributing to an increase in cardiovascular diseases, inconsistent sleep patterns, high levels of stress, and obesity. The European Respiratory Society reported that between 13% and 32% of Europe's elderly population experience sleep apnea.

Due to increased rates of obesity and other lifestyle issues, as well as rising sleep apnea diagnostic rates in both industrialised and developing countries, a substantial patient pool must be treated or managed for the illness. This is encouraging market growth, along with a rise in sleep clinics and sleep technologists globally.

Restraint

High Device Prices

The market's growth is being constrained by a number of challenges even though the sickness and symptoms connected to a sedentary lifestyle are growing more widespread globally. One of them is the expensive price tag placed on the apparatus. The CPAP and PSG sleep apnea machines are the main alternatives for addressing OSA. A CPAP machine in the US may be quite pricey without health insurance, costing between USD 600 and USD 800. Developed countries have sophisticated infrastructure and payment systems. However, patient compensation systems are inadequate in developing countries, and out-of-pocket costs are substantial. The low penetration of medical coverage in these countries also places a limit on the number of patients obtaining care there.

Market Trends

The trend of patients towards technologically advanced devices has tremendously facilitated the development of new choices for the treatment of sleep apnea. For instance, the use of oral devices like the mandibular advancement device (MAD) for OSA therapy has increased as a result of patient dissatisfaction with CPAP machines.

Since it is non-invasive and more affordable than standard polysomnography equipment (PSG), a portable diagnostic instrument known as an Actometer has gained a lot of popularity in sleep clinics. As a result of rising non-adherence to CPAP equipment and rising desire for reasonably priced diagnostic tools, patients are increasingly resorting to mouth appliances and actometers for effective management of sleep apnea.

Table of Contents

Executive Summary

  • Market Overview
  • Wheel of Fortune
  • Research Methodology
  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Parent Market Analysis

  • Market Overview
  • Market Size
  • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Key Market Insights
  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition
  • Market Dynamics & Outlook
  • Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
  • Regulatory Landscape
  • Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact
  • Global Sleep Apnea Devices Market by Device Type
  • Market Overview
  • Therapeutic Devices
  • Diagnostic Devices
  • Global Sleep Apnea Devices Market by End-User
  • Market Overview
  • Sleep Laboratories & Clinics
  • Homecare & Other Settings
  • Global Sleep Apnea Devices Market Size by Region
  • Market Overview
  • North America
  • USA
  • Canada
  • Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
  • Latin America
  • Brazil
  • Rest of Latin America
  • Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA
  • Competitive Landscape
  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
  • By Development
  • By Company
  • By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021
  • Key Company Profiles
  • Koninklijke Philips N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • ResMed
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Fisher & Paykel Healthcare Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Invacare Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • DeVilbiss Healthcare LLC (a subsidiary of Drive DeVilbiss Healthcare)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • BMC Medical Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Natus Medical Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Weinmann Emergency Medical Technology GmbH + Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • SOMNOmedics GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Compumedics Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Braebon Medical Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • APEX Medical Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Lowenstein Medical GmbH & Co. KG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Circadiance LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Curative Medical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Panthera Dental Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • NovaSom Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Inspire Medical Systems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Advanced Brain Monitoring, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
  • Itamar Medical Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦